MeSH D001759 - blastomycosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Amphotericin b | Amphotericin B |  | 1995-03-31 |  |  |
| Fluconazole | Fluconazole |  | 2004-07-29 |  |  | |
| Taro Pharmaceutical | Fluconazole | Fluconazole |  | 2004-07-29 |  |  |
| Glenmark Pharmaceuticals | Fluconazole | Fluconazole |  | 2006-01-25 |  |  |
| Mylan | Fluconazole | Fluconazole |  | 2004-07-29 |  |  |
| Itraconazole | Itraconazole |  | 2012-07-20 |  |  | |
| Mayne Group | Itraconazole | Tolsura | 2023-07-25 | 2018-12-11 |  |  |
| Johnson & Johnson | Itraconazole | Sporanox |  | 1992-09-11 |  |  |
| Sandoz | Itraconazole | Itraconazole |  | 2004-05-28 |  |  |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
50%1/2
Phase 3
89%8/9
Approved: 6Overall Success rate: 44%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use